Did your IVF Treatment Fail?


By identifying potential genetic irregularities or abnormalities, Preimplantation Genetic Diagnosis in IVF Treatment helps in selecting the healthiest embryos for implantation, thereby increasing the chances of a successful pregnancy while minimizing the risk of passing on hereditary diseases.


Preimplantation Genetic Diagnosis in IVF Treatment

Next-Generation Sequencing (NGS) represents the cutting edge of Preimplantation Genetic Diagnosis (PGD) techniques. This advanced form of genetic analysis involves the examination of thousands of genetic markers within embryos, providing an unparalleled depth of insight into their genetic composition. Compared to traditional PGD methods, NGS offers a significantly more comprehensive and precise assessment, making it the most advanced and sophisticated form of genetic screening available in the field of assisted reproductive technology.

The revolutionary genetic analysis technology, NGS, allows scientists to examine DNA sequences with unprecedented speed, accuracy, and depth. This advanced technique enables the simultaneous sequencing of millions of DNA fragments, offering a comprehensive view of an organism's genetic makeup.

In the context of IVF (In Vitro Fertilization), NGS plays a pivotal role in genetic screening of embryos before implantation. It allows fertility specialists to assess thousands of genetic markers, providing detailed insights into the genetic health of embryos. By identifying potential genetic irregularities or abnormalities, NGS helps in selecting the healthiest embryos for implantation, thereby increasing the chances of a successful pregnancy while minimizing the risk of passing on hereditary diseases.

Let's explore how NGS addresses specific challenges encountered in assisted reproduction:


Advanced Maternal Age

Women of advanced maternal age often face increased risks of chromosomal abnormalities in embryos, which can lead to failed implantation or miscarriages. NGS, with its comprehensive genetic screening, proves especially valuable in identifying these abnormalities, aiding fertility specialists in selecting the healthiest embryos for implantation.


Recurrent Pregnancy Loss

Couples experiencing recurrent pregnancy loss often undergo immense emotional stress and seek answers. NGS helps delve deeper into the genetic composition of embryos, providing insights into potential causes of recurrent miscarriages. This assists fertility experts in selecting embryos less likely to result in miscarriage, offering renewed hope for a successful pregnancy.


Genetic Disorders

Individuals carrying genetic disorders or at risk of passing them on to their offspring benefit significantly from NGS. It allows for the precise identification of these genetic conditions within embryos before implantation. For couples with a family history of hereditary diseases, NGS ensures the selection of unaffected embryos, reducing the risk of passing on these disorders to future generations.


Unexplained Infertility

For couples facing unexplained infertility, where standard diagnostic tests yield inconclusive results, NGS can offer a deeper understanding. It provides comprehensive genetic insights that might shed light on underlying factors contributing to infertility, aiding fertility specialists in formulating more targeted treatment plans.


Previous IVF Failures

Individuals who have undergone multiple unsuccessful IVF cycles might find NGS a crucial asset. By analyzing embryos at a genetic level, it enhances the chances of selecting higher-quality embryos for subsequent cycles, potentially improving the likelihood of a successful pregnancy.


Conclusion

Next-Generation Sequencing, NGS in IVF treatment serves as a powerful tool, providing comprehensive genetic insights that significantly contribute to improving success rates. Istanbul MedAssist, leveraging the prowess of NGS, empowers individuals and couples facing these specific challenges, offering advanced genetic screening to enhance their chances of a successful pregnancy.


Preimplantation Genetic Diagnosis in Istanbul, Turkey

Turkey stands at the forefront of advanced IVF technologies, leveraging innovative methodologies like Preimplantation Genetic Diagnosis (PGD) to enhance success rates in fertility treatments. With its commitment to cutting-edge medical advancements, Turkey has emerged as a hub for superior IVF success rates, surpassing those of many countries worldwide. According to reports from reputable sources like the Turkish Society of Reproductive Medicine (TSRM) or articles published in esteemed medical journals, the country's IVF success rates consistently rank among the highest globally, cementing its position as a leader in the field of assisted reproductive technology.

At Istanbul MedAssist, our experienced fertility specialists carefully assess each case, recognizing the uniqueness of every individual's fertility journey. Leveraging their expertise, they craft personalized solutions tailored to specific needs, incorporating cutting-edge technologies like Preimplantation Genetic Diagnosis (PGD). Our comprehensive all-inclusive packages encompass these advanced techniques, ensuring that individuals and couples receive personalized care and sophisticated genetic screening to optimize their chances of a successful pregnancy.



You may be also interested in…

In Istanbul Med Assist your comfort during or after all kinds of procedures is our priority. Whether you are looking for more information, an initial evaluation, or a second opinion, do not hesitate to contact us via Whatsapp at +90 530 884 47 22 and we will get back to you as quickly as we can.

Discover more

Related articles

  • Transportation Services
    (Airport ⇔ Hotel ⇔ Clinic / Office)
  • Medical Consultation
    Appointment Arrangements
  • Medical Follow-Up
  • Interpreting / Translation Services
  • Accommodation in a Five-Star Hotel
    (Including Breakfast)
  • General Personal Support Services
    during Medical Trip
Open chat
1
We're here to help.
Welcome to IMA! We're here to help. How can we assist you today?